Several studies have demonstrated that combining adrenomedullin (ADM) with other biomarkers significantly enhances the sensitivity for diagnosing acute respiratory distress syndrome (ARDS) in septic patients. The gene discussed is ADM; the disease is acute respiratory distress syndrome.